Research Information System
Signa Vitae, vol.20, no.12, pp.86-92, 2024 (SCI-Expanded)
Asprosin is a polypeptide with versatile metabolic roles, peripherally and centrally, secreted mainly by white adipose tissue during fasting. High asprosin levels may be a risk factor for conditions such as obesity, diabetic nephropathy, and retinopathy and are positively associated with inflammatory markers. Our study aimed to investigate the predictive value of asprosin in diagnosing sepsis. The prospective case-controlled study included 80 individuals with a 1:1 ratio of sepsis and healthy individuals. Receiver operating characteristic curve (ROC) analysis was used to evaluate the diagnostic impact of asprosin on sepsis patients. The sepsis patients were 24 women and 16 men, with a median age of 73 years (Interquartile Range (IQR) 63–79). The control group included 40 healthy individuals, 24 women and 16 men, with a median age of 73 (IQR 63–79). While the asprosin level of the control group was 0.29 ng/mL, that of the sepsis group was 0.77 ng/mL (p < 0.001). When the cut-off value was accepted as 0.452, the sensitivity and specificity of asprosin were 85% and 80%. The area under the curve (AUC) of asprosin was found to be 0.904 (95% Confidence Interval (CI): 0.841–0.967, p < 0.001). In conclusion, higher asprosin levels were found in sepsis than in control patients, and asprosin had a high discriminatory ability diagnosis for sepsis.